K. Zamborsky

Automated Manufacture of Autologous CD19 CAR-T Cells for Treatment of Non-hodgkin Lymphoma

R. Sékaly, R. Orentas, M. de Lima, 2020, Frontiers in Immunology.

Prophylactic Tocilizumab Prior to Anti-CD19 CAR-T Cell Therapy for Non-Hodgkin Lymphoma

R. Sékaly, M. de Lima, P. Caimi, 2021, Frontiers in Immunology.

A Phase I study to determine maximum tolerated dose of ex vivo expanded natural killer cells derived from unrelated, HLA-disparate adult donors.

H. Lazarus, M. Gallogly, B. Cooper, 2022, Transplantation and cellular therapy.